INFORMAZIONI SU QUESTO ARTICOLO

Cita

Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer. 2010; 46(4): 765-781.10.1016/j.ejca.2009.12.01420116997Search in Google Scholar

Lung cancer incidence and mortality worldwide in 2008. Summary. ( http://globocan.iarc.fr/factsheets/cancers/lung.aspSearch in Google Scholar

Lonardo F, Li X, Kaplun A, Soubani A, Sethi S, Gadgeel S, Sheng S. The natural tumor suppressor protein maspin and potential application in non small cell lung cancer. Curr Pharm Des. 2010; 16(16): 1877-1881.10.2174/138161210791208974290849520337574Search in Google Scholar

Sculier JP, Chansky K, Crowley JJ, Van Meerbeeck J, Goldstraw P; International Staging Committee and Participating Institutions. The impact of additional prognostic factors on survival and their relationship with the anatomical extent of disease expressed by the 6th Edition of the TNM Classification of Malignant Tumors and the proposals for the 7th Edition. J Thorac Oncol. 2008; 3(5): 457-466.10.1097/JTO.0b013e31816de2b818448996Search in Google Scholar

Valerianova ZG, Vukov MI, Dimitrova NE, Eds. Cancer Incidence in Bulgaria 2006, 1st ed. Sofia: AVIS-24 Ltd, 2008.Search in Google Scholar

Zochbauer-Muller S, Gazdar AF, Minna JD. Molecular pathogenesis of lung cancer. Annu Rev Physiol. 2002; 64: 681-708.10.1146/annurev.physiol.64.081501.15582811826285Search in Google Scholar

Pignon JP, Tribodet H, Scagliotti GV, Douillard JY, Shepherd FA, Stephens RJ, Dunant A, Torri V, Rosell R, Seymour L, Spiro SG, Rolland E, Fossati R, Aubert D, Ding K, Waller D, Le Chevalier T; LACE Collaborative Group. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group. J Clin Oncol. 2008; 26(21): 3552-3559.10.1200/JCO.2007.13.903018506026Search in Google Scholar

Goldstraw P, Crowley J, Chansky K, Giroux DJ, Groome PA, Rami-Porta R, Postmus PE, Rusch V, Sobin L; International Association for the Study of Lung Cancer International Staging Committee; Participating Institutions. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol. 2007; 2(8): 706-714.10.1097/JTO.0b013e31812f3c1a17762336Search in Google Scholar

Fulda S. Tumor resistance to apoptosis. Int J Cancer. 2009; 124(3): 511-515.10.1002/ijc.2406419003982Search in Google Scholar

Horn L, Sandler A. Epidermal growth factor receptor inhibitors and antiangiogenic agents for the treatment of non-small cell lung cancer. Clin Cancer Res. 2009; 15(16): 5040-5048.10.1158/1078-0432.CCR-09-0520352818219671872Search in Google Scholar

Schulz WA. Apoptosis and replicative senescence in cancer. In: Schulz WA, Ed. Molecular Biology of Human Cancers. Dordrecht: Springer Science + Business Media. 2005: 145.Search in Google Scholar

Kang BN, Ahmad AS, Saleem S, Patterson RL, Hester L, Doré S, Snyder SH. Death-associated protein kinase-mediated cell death modulated by interaction with DANGER. J Neurosci. 2010; 30(1): 93-98.10.1523/JNEUROSCI.3974-09.2010284072020053891Search in Google Scholar

Jang CW, Chen CH, Chen CC, Chen J, Su YH, Chen RH. TGF-beta induces apoptosis through Smad-mediated expression of DAP-kinase. Nature Cell Biol. 2001; 4(1): 51-58.10.1038/ncb73111740493Search in Google Scholar

Mashkova TD, Oparina NIu, Zinov'eva OL, Kropotova ES, Dubovaia VI, Poltaraus AB, Fridman MV, Kopantsev EP, Vinogradova TV, Zinov'eva MV, Laktionov KK, Kasymova OT, Zborovskaia IB, Sverdlov ED, Kiselev LL. Transcription TIMP3, DAPk1 and AKR1B10 genes in squamous cell lung cancer. Mol Biol (Mosk). 2006; 40(6): 1047-1054.10.1134/S002689330606014817209422Search in Google Scholar

Han W, Wang T, Reilly AA, Keller SM, Spivack SD. Gene promoter methylation assayed in exhaled breath, with differences in smokers and lung cancer patients. Respir Res. 2009; 10: 86.10.1186/1465-9921-10-86275991619781081Search in Google Scholar

Wang Y, Zhang D, Zheng W, Luo J, Bai Y, Lu Z. Multiple gene methylation of nonsmall cell lung cancers evaluated with 3-dimensional microarray. Cancer. 2008; 112(6): 1325-1336.10.1002/cncr.2331218286531Search in Google Scholar

Liu Y, Gao W, Siegfried JM, Weissfeld JL, Luketich JD, Keohavong P. Promoter methylation of RASSF1A and DAPK and mutations of K-ras, p53, and EGFR in lung tumors from smokers and never-smokers. BMC Cancer. 2007; 7: 74.10.1186/1471-2407-7-74187781217477876Search in Google Scholar

Logue SE, Martin SJ. Caspase activation cascades in apoptosis. Biochem Soc Trans. 2008; 36(Pt. 1): 1-9.10.1042/BST036000118208375Search in Google Scholar

Neumann L, Pforr C, Beaudouin J, Pappa A, Fricker N, Krammer PH, Lavrik IN, Eils R. Dynamics within the CD95 death-inducing signaling complex decide life and death of cells. Mol Syst Biol. 2010; 6: 352.10.1038/msb.2010.6285844220212524Search in Google Scholar

Yang Q, Kiernan CM, Tian Y, Salwen HR, Chlenski A, Brumback BA, London WB, Cohn SL. Methylation of CASP8, DCR2, and HIN-1 in neuroblastoma is associated with poor outcome. Clin Cancer Res. 2007; 13(11): 3191-3197.10.1158/1078-0432.CCR-06-284617545522Search in Google Scholar

Stupack DG, Teitz T, Potter MD, Mikolon D, Houghton PJ, Kidd VJ, Lahti JM, Cheresh DA. Potentiation of neuroblastoma metastasis by loss of caspase-8. Nature. 2006; 439(7072): 95-99.10.1038/nature0432316397500Search in Google Scholar

Su H, Bidere N, Zheng L, Cubre A, Sakai K, Dale J, Salmena L, Hakem R, Straus S, Lenardo M. Requirement for caspase-8 in NF-kappa-B activation by antigen receptor. Science. 2005; 307(5714): 1465-1468.10.1126/science.110476515746428Search in Google Scholar

Bae J, Leo CP, Hsu SY, Hsueh AJW. MCL1S, a splicing variant of the antiapoptotic BCL-2 family member MCL-1, encodes a proapoptotic protein possessing only the BH3 domain. J Biol Chem. 2000; 275(33): 25255-25261.10.1074/jbc.M90982619910837489Search in Google Scholar

ISSN:
1311-0160
Lingua:
Inglese
Frequenza di pubblicazione:
2 volte all'anno
Argomenti della rivista:
Medicine, Basic Medical Science, other